Rivero-Juarez Antonio, Lopez-Lopez Pedro, Frias Mario, Rivero Antonio
Infectious Diseases Unit, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía de Córdoba, Universidad de Córdoba, Córdoba, Spain.
Front Microbiol. 2019 Jun 26;10:1425. doi: 10.3389/fmicb.2019.01425. eCollection 2019.
The hepatitis E virus (HEV) represents a major cause of acute hepatitis worldwide. The majority of HEV cases occur in low-income countries, mainly Asia and Africa, where HEV causes large outbreaks associated with the consumption of contaminated water and high mortality in specific populations. In high-income countries, HEV infection is considered a zoonotic disease that is linked to the consumption of contaminated food. Although a high proportion of cases have self-limiting asymptomatic or subclinical infections, immunosuppression may modify the pathogenesis and clinical impact of this emerging disease.
Here, we review the current knowledge about the epidemiology, diagnosis, clinical manifestations, management and prevention of HEV infection in HIV-infected subjects.
Despite the increasing knowledge about the pathogenesis, epidemiology and clinical impact of HEV infection, several major factors are faced by HIV-infected patients, including treatment recommendations, immunization and risk practices.
戊型肝炎病毒(HEV)是全球急性肝炎的主要病因。大多数戊型肝炎病例发生在低收入国家,主要是亚洲和非洲,在这些地区,戊型肝炎会引发与饮用受污染水相关的大规模疫情,并在特定人群中导致高死亡率。在高收入国家,戊型肝炎感染被认为是一种人畜共患病,与食用受污染食物有关。尽管大部分病例为自限性无症状或亚临床感染,但免疫抑制可能会改变这种新发疾病的发病机制和临床影响。
在此,我们综述了目前关于HIV感染患者中戊型肝炎感染的流行病学、诊断、临床表现、管理和预防的知识。
尽管对戊型肝炎感染的发病机制、流行病学和临床影响的认识不断增加,但HIV感染患者仍面临几个主要因素,包括治疗建议、免疫接种和风险行为。